LEADER 01100nam0 22002893i 450 
001 RMS1004600
005 20231121125808.0
010   $a0471971170
100   $a20120525d1997    ||||0itac50      ba
101 | $aeng
102   $agb
181  1$6z01$ai $bxxxe  
182  1$6z01$an
200 1 $aModern strategy for Preclinical pharmaceutical R&D$eTowards the virtual research company$fDavid Cavalla$gwith contributions from John Flack and Richard Jennings
210   $aChichester$cJohn Wiley & Sons$dc1997
215   $ax, 218 p.$cill.$d23 cm
700  1$aCavalla$b, David$3RMSV421335$4070$01340365
702  1$aFlack$b, John$3RMSV421337
702  1$aJennings$b, Richard$3RMSV421340
801  3$aIT$bIT-01$c20120525
850   $aIT-FR0017          
899   $aBiblioteca umanistica Giorgio Aprea$bFR0017          
912   $aRMS1004600
950  0$aBiblioteca umanistica Giorgio Aprea$d 52MAG       8/185$e 52DSS0000020195  VMB RS                    $fA $h20120525$i20120525
977   $a 52
996   $aModern strategy for Preclinical pharmaceutical R&D$93634928
997   $aUNICAS